The Asia Pacific Policosanol Market would witness market growth of 6.7% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 102.95 Tonnes, showcasing a growth of 6.4% (2019-2022).
One primary benefit of the supplement is its potential to reduce low-density lipoprotein (LDL) cholesterol levels. LDL cholesterol is frequently labeled "bad cholesterol" due to the association between increased levels and a heightened susceptibility to cardiovascular diseases. Policosanol's ability to lower LDL cholesterol has positioned it as a dietary supplement of interest for individuals seeking non-pharmaceutical interventions for cholesterol management.
Moreover, the supplement is a key component in cardiovascular health supplements, both as a standalone product and in combination with other heart-healthy ingredients. These supplements cater to a broad consumer base seeking comprehensive solutions for heart health maintenance, making the supplement a staple in this market segment. The primary focus of cardiovascular health supplements containing the supplement is to support cholesterol management. Policosanol's potential to lower LDL cholesterol levels and its reported ability to increase HDL cholesterol positions it as a valuable component in formulations designed to address various aspects of lipid profile regulation.
As per the data from the Government of India, the country produced an unprecedented quantity of sugarcane, exceeding 5000 lakh metric tons (LMT), during the sugar season of 2021-22 (October to September). Additionally, as per the data from the State Council of China, the population of mainland Chinese citizens aged 60 or older has reached 264.02 million, with 190.64 million individuals aged 65 or older, or 13.5% of the total population. Thus, growing sugarcane production and the rising aging population in the Asia Pacific will boost the demand for the supplement in the region.
The China market dominated the Asia Pacific Policosanol Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $58,420 Thousands by 2030. The Japan market is registering a CAGR of 6.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.4% during (2023 - 2030).
Based on Source, the market is segmented into Sugarcane, Wheat Germ, Beeswax, and Others. Based on Application, the market is segmented into Pharmaceutical Drugs, Dietary Supplements, Personal Care & Cosmetics, and Animal Feed. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Policosanol Market is Predict to reach $475.8 Million by 2030, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sabinsa corporation, Sunpure Extracts Private Limited, SHREEJI PHARMA International, Huzhou Shengtao Biotechnology Co., Ltd., Botanic Healthcare Group, Bioriginal Food & Science Corp (Cooke, Inc.), NOW Health Group, Inc. and India Glycols Limited
By Source (Volume, Tonnes, USD Million, 2019-2030)
By Application (Volume, Tonnes, USD Million, 2019-2030)
By Country (Volume, Tonnes, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
